Share on StockTwits

Shares of Surgical Care Affiliates (NASDAQ:SCAI) have been given an average rating of “Buy” by the nine brokerages that are covering the stock, StockRatingsNetwork reports. One equities research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and six have given a buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $35.35.

Separately, analysts at Zacks downgraded shares of Surgical Care Affiliates from a “neutral” rating to an “underperform” rating in a research note on Tuesday, August 26th. They now have a $27.10 price target on the stock.

Surgical Care Affiliates (NASDAQ:SCAI) opened at 29.76 on Wednesday. Surgical Care Affiliates has a one year low of $25.50 and a one year high of $37.69. The stock’s 50-day moving average is $29.32 and its 200-day moving average is $29.75.

Surgical Care Affiliates (NASDAQ:SCAI) last posted its quarterly earnings results on Wednesday, August 13th. The company reported $0.45 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.25 by $0.20. On average, analysts predict that Surgical Care Affiliates will post $1.35 earnings per share for the current fiscal year.

In other Surgical Care Affiliates news, COO Michael A. Rucker unloaded 1,500 shares of the company’s stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $29.67, for a total transaction of $44,505.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Surgical Care Affiliates,Inc operates surgical facilities, including surgery centers, surgical hospitals, and hospital surgery departments.

Receive News & Ratings for Surgical Care Affiliates Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgical Care Affiliates Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.